Skip to content
Friday 28 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 14 February 2017 11:44 am

US extends probe into $43bn ChemChina-Syngenta deal

By: William Turvill

Add as a preferred source on Google

The US has asked for more information for its probe into China’s largest ever foreign acquisition.

But Syngenta, the Swiss chemical company being taken over by ChemChina in a $43bn (£34bn) deal, said the transaction should still complete in the first half of this year.

“We have received a second request but do not expect this to cause a delay,” Syngenta said, confirming the US Federal Trade Commission probe extension.

Read more: Syngenta shares fight back as boss eases ChemChina regulatory fears

“We expect to close the transaction in the second quarter.”

ChemChina and Syngenta announced the $43bn, $465 per share deal in February last year.

The deal was initially expected to complete by the end of 2016, but the deadline has been pushed back, initially to the first quarter of 2017 and then to the second, due to various antitrust investigations. The European Commission has a deadline of 12 April to approve the deal.

The takeover is one of three mega-deals in the agrochemicals industry currently agreed but not completed.

Read more: S&P puts Syngenta on negative watch after ChemChina bid

US chemical companies DuPont and Dow Chemical agreed to a $130bn merger in December 2015. The DuPont-Dow Chemical deal is expected to complete in the first half of this year after also experiencing delays along the way.

Germany’s Bayer, meanwhile, wants to complete its $66bn takeover of US seeds firm Monsanto by the end of this year.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • International
  • M&A

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

More from Morning Wire

  • Reform’s Richard Tice under parliamentary investigation

    Politics
    Reform UK leader Nigel Farage and Deputy Leader Richard Tice are set to meet with Andrew Bailey to discuss interest rates and stablecoins.
  • Heineken-owned pubs group faces probe over eviction threat

    Hospitality
    Hand holding a 4-pack of green Heineken beer cans with red stars and white lettering
  • Trainline and Virgin Atlantic face watchdog’s ‘drip pricing’ probe

    Transport & Infrastructure
    A ruling by the UK ad watchdog has raised questions over Virgin Atlantic's "groundbreaking" biofuel-powered flight across the Atlantic last November.
  • As it happened: FTSE 100 jumps in best streak since May; Vistry, Melrose lead risers

    FTSE 100 Live
    LSEG signage and digital stock market ticker displays inside a modern financial building.
  • Competition watchdog clears Paramount Warner Bros acquisition

    Media
    Paramount, Netflix, Warner logos; media giants intensifying streaming competition and strategic industry shifts
  • Thames Water faces fresh threat to survival after pensions regulation breach

    Water
    Thames Water infrastructure with pipes and maintenance workers, highlighting water management efforts in London
  • Incoming FRC chair sits on board of construction group facing criminal probe

    Accountancy
    Blonde woman in a blue and black patterned jacket smiling in front of a window
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook